Asphaug L, Akslen LA, Blix ES, Boge B, Borgen EF, Brekke MB, Falk RS, Geitvik GA, Gilje B, Gravdehaug B, Heie A, Janssen E, Kiserud CE, Kursetgjerde T, Langerød A, Lømo J, Mannsåker B, Mortensen E, Olsson P, Porojnicu AC, Raj SX, Roe OD, Russnes HEG, Skjerven HK, Songe-Møller Set al.(2025) Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives Clin Breast Cancer, 25(6), e721-e730 DOI 10.1016/j.clbc.2025.04.011, PubMed 40348620
Fjørtoft MO, Garred Ø, Lingjærde OC, Lande KT, Ottestad L, Bergheim IR, OSBREAC, Lømo J, LaMont C, Myklebust JH, Russnes H, Huse K, Rye IH(2025) Single-cell analysis reveals tumour size as a key driver of immune cell profile alterations in primary breast tumours and corresponding lymph nodes BJC Rep, 3(1), 35 DOI 10.1038/s44276-025-00152-3, PubMed 40394379
Henkel PS, Aas E, Russnes HG, Dyvik I, Fagereng GL, Helland Å, Røgenes H, Lien TG, Pedersen K(2025) Micro-costing Study of Genomic Profiling for Precision Cancer Medicine: Application from the National Infrastructure for Precision Diagnostics in Norway J Mol Diagn(in press) DOI 10.1016/j.jmoldx.2025.06.006, PubMed 40712993